Novela Neurotech, a leader in remote neurological care based in Alameda, California, is selected as part of the 2021 cohort of the Rosenman Innovators. Based at the University of California, San Francisco (UCSF), Rosenman Innovators are a prestigious group of early-stage companies chosen for their innovative technologies and patient impact.
March 30
2021
Novela Neurotech Joins Sofie’s Journey in a Strategic Partnership to Promote Epilepsy Awareness
Novela Neurotech, a digital healthcare company specializing in personalized remote care for epilepsy and other neurological conditions, announces a strategic partnership with Sofie’s Journey to promote epilepsy awareness and access to cutting-edge epilepsy care solutions.
December 8
2020
Novela Neurotech Partners with Epilepsy Advocate Brain Ablaze in Memorable Motto Challenge to Raise Epilepsy Awareness
This year we partnered with Novela Neurotech to bring a bit of fun to our Epilepsy Awareness Month with our Memorable Motto Challenge. Novela Neurotech then used the motto “The Patients are the Experts!” in a wonderfully designed T-shirt hosted in our store.
December 5
2020
Novela Neurotech's nEureka® 2020 Epilepsy Challenge featured at IEEE Signal Processing in Medicine and Biology Symposium
To celebrate the 10th year of the symposium, we are collaborating with Novela Neurotech and NeuroTechX to host the Neureka 2020 Epilepsy Challenge.
October 30
2020
Novela Neurotech to Present nEureka® for Epilepsy Platform at Epilepsy Awareness Day at Disneyland
Novela Neurotech, a NeuroData company enabling personalized remote care for chronic neurological conditions, will showcase its nEureka® for Epilepsy smartwatch-based platform at the virtual Epilepsy Awareness Day at Disneyland (EADDL), November 2 at 9:30 AM PT.
September 23
2020
Novela Neurotech to Present nEureka® for Epilepsy Platform at CapCon 2020 Venture Conference
Novela Neurotech, a Data-as-a-Service company developing personalized remote epilepsy care using connected consumer data, will showcase its nEureka® for Epilepsy platform at the virtual CapCon 2020 Venture Conference, Sep 29 to Oct 1, 2020.
August 5
2020
Novela Neurotech Featured on Epilepsy Foundation NorCal's Research Spotlight
Research and development of new tools to fight and better understand seizures are critical aspects of our mutual goal to create a seizure-free world. We want to help organizations get your feedback and participation to shorten the time for those tools to get to market.
June 2
2020
How a Crowdsourcing Challenge Turbocharged Brain Research During Lockdown
In mid-March, a trifecta of academic, non-profit, and commercial neurotech companies united to launch a neuroscientific challenge that embodied a more collaborative future for solving the brain, while physically apart and working from home.
June 1
2020
Novela Neurotech Seeks to Accelerate Neurological Treatments with Brain Decoding as a Service
Novela Neurotech is a spin off from a Canadian university, the University of Waterloo. We have a long track record of university research and development in what we call the field of neuromodulation, which is basically a way to alter brain functions through different modalities, such as using electricity to change the way brain cells communicate.
May 29
2020
“BIOMED IRREGULARS” WON THE FIRST PLACE IN NEUREKA CHALLENGE!!!
A researcher team from STADIUS: “Biomed Irregulars” won the first place in Neureka Challenge!!! Neureka challenge was a month-long challenge organized by Novela Neurotech and NeuroTechX on seizure prediction using the TUH EEG Seizure dataset (one of the biggest available seizure datasets).
April 27
2020
Novela Neurotech Appoints Aiman Abdel-Malek, Ph.D., to Board of Directors
As a highly experienced business strategic visionary leader, Dr. Abdel-Malek will support Novela in discovering dynaceutical therapies for brain disorders.
April 23
2020
Novela Neurotech joins INCF's Industry Advisory Council to advance open neuroscience
By partnering with INCF, one of the world’s largest institutions promoting data and software reuse and reproducibility in brain research, Novela positions itself as an industry leader in neuroscience data sharing and collaboration.
April 15
2020
Novela Featured in San Francisco Business Times: An Island of Innovation
Alameda is known for many things—among them, the monthly antiques fair, the former Naval Air Station and the U.S.S. Hornet, spirits distilleries, a vintage pinball museum, and as the birthplace of popsicles and creamy peanut butter.
April 1
2020
Alameda Magazine [print], April, 2020: “Alameda’s Implant Pioneer” by Keith Gleason
April 1
2020
Online Neureka™ challenge launches to crowdsource EEG solutions for epilepsy
Novela Neurotech and NeuroTechX are teaming up in an effort to accelerate epilepsy research
March 15
2020
5 Top Emerging Neurotechnology Startups
The US-based startup Novela Neurotechnology builds Neureka, a smart platform to understand and decode neurological activity in the brain using artificial intelligence. Neureka, the startup’s platform combines smart neural interfaces and scheduled delivery of neuromodulation that results in accelerated drug discovery.
February 6
2020
CRANIA to host collaborative neuromodulation workshop with Novela Neurotech and Hahn-Schickard
CRANIA, Novela Neurotech and Hahn-Schickard unites to accelerate the translation of Novela’s open source neuromodulation research kit.
February 4
2020
Novela Neurotech teams up with UCSF to break down neurodata borders
Novela Neurotech teams up with UCSF to break down neurodata borders. Just as computer scientists developed standards to deliver digital content across the globe to your laptop, neuroscientists are working to break down barriers in data sharing.
January 14
2020
Novela Neurotech participates in the 38th J. P. Morgan Healthcare Conference 2020
San Francisco, CA — Novela Neurotech, a neurotechnology company developing next-generation neural prosthesis for epilepsy treatment, will showcase its prototype system at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, January 13-16, 2020.
January 14
2020
Novela Neurotech showcases smart neural interface at Creative Destruction Lab
Novela Neurotech, a MedTech company developing AI-powered wireless, “smart” neural interface systems, joins Canada’s Creative Destruction Lab to further fine-tune its health technologies to the needs of patients with difficult neurological disorders.
November 12
2019
Novela Neurotech begins testing wireless, read-write capable brain prosthesis
Consciousness is one of the brain’s most enigmatic mysteries. A new theory, inspired by thermodynamics, takes a high-level perspective of how neural networks in the brain transiently organize to give rise to memories, thought and consciousness.
October 23
2019
A New Theory of Brain Organization takes aim at the Mystery of Consciousness
Novela Neurotech, a MedTech company developing AI-powered wireless, “smart” neural interface systems, joins Canada’s Creative Destruction Lab to further fine-tune its health technologies to the needs of patients with difficult neurological disorders.
July
2019
Novela’s Neureka™ and the Future of Neurostimulation
“Neurostimulation is emerging as a novel non-pharmacological way of treating brain disorders and is showing far greater efficacy with fewer side effects.”
January
2019
Novela Inaugurates R&D Center
Based in Ontario, Canada.
R&D Hub will facilitate collaboration with CRANIA and access to tier-1 talent in the Waterloo and Toronto areas.
January, we opened our research and development (R&D) center in Waterloo, Canada. Working in concert with the California headquarters, the center will focus on the advancement of the fabrication process of Novela’s neural implant devices.
January 24
2019
In The Press
Novela’s hometown newspaper the Alameda Sun featured us in their Thursday 1/24/19 issue “Novela’s long-term vision is to extend memory and brain processing speed, and even to add built-in cloud connectivity as well as expand human senses.”
December
2018
In The Spotlight
Mark Valentine, Senior VP, Business Development & IP Portfolio
“I’ve witnessed firsthand the need for medical devices and treatments in those regions less fortunate than the western world. I think that’s why I’m so attracted to medical devices and technology companies.”
March
2018
Novela Neurotechnologies: Ushering in the Next-Generation of Personalized Neurological Care
The company develops biocompatible neural implants that monitor, recognize, and intervene in neurological disorders through personalized treatment protocols.